Industry Insight
Company News
Industry Insights

Home > News > Industry Insight > GRAS+ Infant Whitelist Recognition: How BLa80 Builds its Safety Fortress?

GRAS+ Infant Whitelist Recognition: How BLa80 Builds its Safety Fortress?

July 24 2025

Bifidobacterium animalis subsp. lactis BLa80

Wecare Probiotics' Bifidobacterium animalis subsp. lactis BLa80 has made history as the first probiotic strain from mainland China to enter the Infant Whitelist with both self-affirmed GRAS and FDA GRAS status. Here's how Wecare built an ironclad safety fortress for BLa80:

GRAS: The Gold Standard of Safety

GRAS status, governed by the FDA, marks ingredients as safe for food use through rigorous science or proven history. BLa80’s dual GRAS status set a new benchmark for probiotic excellence.

The BLa80 GRAS Journey

BLa80's strong safety profile is built on meticulous research. It involves:

Precise Strain Identification: Comprehensive genomic analysis confirms BLa80's identity and ensures no harmful genes.

Supportive Pre-clinical Studies: Rigorous in vitro and in vivo tests confirm safety, including tolerance and antibiotic resistance.

Extensive Clinical Evidence: Human trials, including those with infants, have consistently shown BLa80 to be safe and well-tolerated.

History of Safe Use: As a Bifidobacterium lactis strain, BLa80 belongs to a group with a long history of safe use in food and infant formulas.

Wecare's Game-Changing Win

BLa80’s GRAS double crown is a global game-changer, unlocking markets and redefining probiotic safety.

Contact us to learn how BLa80 can benefit your products!

Learn more: 【 http://www.wecare-life.com 】

Contact Us: 【 sales@wecare-life.com 】


No.999,Guangming Rd., Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province, China
Online Message
Leave a Message